Gastroenterology
Volume 123, Issue 2 , Pages 407-413 , August 2002

Randomized trial of medical or endoscopic therapy to prevent recurrent ulcer hemorrhage in patients with adherent clots

  • Dennis M. Jensen

      Affiliations

    • CURE Digestive Disease Research Center, UCLA School of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles, California
    • ,
  • Thomas O.G. Kovacs

      Affiliations

    • CURE Digestive Disease Research Center, UCLA School of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles, California
    • ,
  • Rome Jutabha

      Affiliations

    • CURE Digestive Disease Research Center, UCLA School of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles, California
    • ,
  • Gustavo A. Machicado

      Affiliations

    • CURE Digestive Disease Research Center, UCLA School of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles, California
    • Northridge Hospital Medical Center, Van Nuys, California
    • ,
  • Ian M. Gralnek

      Affiliations

    • CURE Digestive Disease Research Center, UCLA School of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles, California
    • ,
  • Thomas J. Savides

      Affiliations

    • UCSD School of Medicine, San Diego, California
    • ,
  • James Smith

      Affiliations

    • Oschner Foundation Clinic, New Orleans, Louisiana
    • ,
  • Mary Ellen Jensen

      Affiliations

    • CURE Digestive Disease Research Center, UCLA School of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles, California
    • ,
  • Gwen Alofaituli

      Affiliations

    • CURE Digestive Disease Research Center, UCLA School of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles, California
    • ,
  • Jeff Gornbein

      Affiliations

    • CURE Digestive Disease Research Center, UCLA School of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles, California

Received 18 February 2002 ,Accepted 28 February 2002.

  • Image Result

    The recurrence of ulcer hemorrhage following randomization to medical vs. endoscopic therapy, up to the time of hospital discharge for patients with nonbleeding adherent clots. *Indicates a significan

    The recurrence of ulcer hemorrhage following randomization to medical vs. endoscopic therapy, up to the time of hospital discharge for patients with nonbleeding adherent clots. *Indicates a significant difference (P = 0.011).

☆ Address requests for reprints to: Dennis M. Jensen, M.D., CURE Digestive Disease Research Center, Building 115, Room 318, VA Greater Los Angeles Healthcare System, 11301 Wilshire Boulevard, Los Angeles, California 90073. e-mail: djensen@mednet.ucla.edu; fax: (310) 794-2908.

☆☆ Supported in part by NIH RO1 DK 33273, NIH 1K24DK 02650, and NIH DK 41301 (CURE Human Studies CORE), by Microvasive-Boston Scientific Corporation, and by a Veterans Administration HSR & D Career Development Award (to I.M.G.).

PII: S0016-5085(02)00118-X

doi: 10.1053/gast.2002.34782

Gastroenterology
Volume 123, Issue 2 , Pages 407-413 , August 2002

Article Tools

* Image Usage & Resolution